Evidence map›Paper›PMID 29463859›Full record

ArticleScientific reports2018

Biomining of MoS

Sibel Cetinel, Wei-Zheng Shen, Maral Aminpour, Prasanna Bhomkar, Feng Wang, Elham Rafie Borujeny, Kumakshi Sharma, Niloofar Nayebi, Carlo Montemagno

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sibel CetinelIngenuity Lab, 11421 Saskatchewan Drive, T6G 2M9, Edmonton, AB, Canada.ORCID 0000-0003-0248-9447
Wei-Zheng ShenIngenuity Lab, 11421 Saskatchewan Drive, T6G 2M9, Edmonton, AB, Canada.
Maral AminpourIngenuity Lab, 11421 Saskatchewan Drive, T6G 2M9, Edmonton, AB, Canada.
Prasanna BhomkarIngenuity Lab, 11421 Saskatchewan Drive, T6G 2M9, Edmonton, AB, Canada.ORCID 0000-0002-8864-004X
Feng WangIngenuity Lab, 11421 Saskatchewan Drive, T6G 2M9, Edmonton, AB, Canada.
Elham Rafie BorujenyIngenuity Lab, 11421 Saskatchewan Drive, T6G 2M9, Edmonton, AB, Canada.
Kumakshi SharmaIngenuity Lab, 11421 Saskatchewan Drive, T6G 2M9, Edmonton, AB, Canada.
Niloofar NayebiIngenuity Lab, 11421 Saskatchewan Drive, T6G 2M9, Edmonton, AB, Canada.
Carlo MontemagnoIngenuity Lab, 11421 Saskatchewan Drive, T6G 2M9, Edmonton, AB, Canada. chancellor@siu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomining of valuable metals using a target specific approach promises increased purification yields and decreased cost. Target specificity can be implemented with proteins/peptides, the biological molecules, responsible from various structural and functional pathways in living organisms by virtue of their specific recognition abilities towards both organic and inorganic materials. Phage display libraries are used to identify peptide biomolecules capable of specifically recognizing and binding organic/inorganic materials of interest with high affinities. Using combinatorial approaches, these molecular recognition elements can be converted into smart hybrid biomaterials and harnessed for biotechnological applications. Herein, we used a commercially available phage-display library to identify peptides with specific binding affinity to molybdenite (MoS

Identifiers

PMID29463859
PMCPMC5820330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.